Company Filing History:
Years Active: 2017-2021
Title: Krzysztof Darlak: Innovator in Pharmaceutical Formulations
Introduction
Krzysztof Darlak is a notable inventor based in Newton, MA (US), recognized for his contributions to the field of pharmaceutical formulations. With a total of four patents to his name, Darlak has made significant strides in developing innovative solutions for medical applications.
Latest Patents
Darlak's latest patents include "Peptidomimetic macrocycles and formulations thereof," which focuses on aqueous pharmaceutical formulations for parenteral administration. These formulations comprise peptidomimetic macrocycles that bind to MDM2 and/or MDMX proteins, offering methods for treating various diseases and disorders. Another significant patent is for "Disubstituted amino acids and methods of preparation and use thereof," which provides crystalline α,α-disubstituted amino acids and their crystalline salts, including methods for their preparation and use.
Career Highlights
Krzysztof Darlak is currently employed at Aileron Therapeutics, Inc., where he continues to advance his research and development efforts in the pharmaceutical industry. His work is characterized by a commitment to innovation and improving therapeutic options for patients.
Collaborations
Darlak collaborates with esteemed colleagues, including Noriyuki Kawahata and Sameer Ahmed Athamneh, contributing to a dynamic research environment that fosters creativity and scientific advancement.
Conclusion
Krzysztof Darlak's innovative work in pharmaceutical formulations exemplifies the impact of dedicated inventors in the medical field. His patents reflect a commitment to addressing complex health challenges through scientific innovation.